Health Sciences In The Media

The Arizona Poison and Drug Information Center and other agencies are issuing a warning regarding fentanyl found in cocaine.

Metfora has announced an award to pursue the detection of chronic diseases via multiplex analysis of circulating metabolites. The diagnostic technology was originally developed by College of Medicine – Tucson associate professors Ruslan Rafikov, PhD, and Olga Rafikova, MD, PhD.

The rate of colorectal cancer has been rising among adults younger than 50. Some groups have been hit by the rising trend more than others.

A new study finds that the design of workspaces has a real effect on the satisfaction of employees and their work performance. Esther Sternberg, MD, professor of medicine and director of research for the Andrew Weil Center for Integrative Medicine in the College of Medicine – Tucson, co-authored the study and is quoted.

Due to recent cases and one known death, several agencies are issuing a warning regarding fentanyl found in cocaine. Steven Dudley, PharmD, DABAT, director of the Arizona Poison and Drug Information Center, is quoted.

Ivo Abraham, PhD, professor of practice in the R. Ken Coit College of Pharmacy, continues to examine how biosimilar guidelines from the World Health Organization have changed over time and how they view interchangeability and animal study requirements.

Despite a barrage of national headlines this past week, UArizona experts say the theory that the COVID-19 virus originated from a Chinese lab leak isn’t credible at this point. Felicia Goodrum, PhD, professor of immunobiology in the College of Medicine – Tucson, is quoted.

The U.S. Preventive Services Task Force did not include people age 65 and older in its recommendation last year to screen adults for anxiety. The task force noted that questionnaires used to screen for anxiety may be unreliable for older adults.

Eight local nonprofits will vie for more than $115,000 at the eighth annual "Fast Pitch Tucson" to be held March 30 at the UArizona Health Sciences Innovation Building.

For older adults with clinical depression that has not responded to standard treatments, adding the drug aripiprazole to an antidepressant they’re already taking is more effective than switching from one antidepressant to another, according to a new multicenter study.